Board of Directors

John Haurum, MD DPhil

John Haurum, MD DPhil

Chairman


Non-executive Director in several European biotech companies: Agomab, CatalYm, Neophore, Storm, Synact, Synklino

Jeroen Bakker, PhD

Jeroen Bakker, PhD

Novo Seeds


Principal at Novo Holdings and part of the Novo Seeds team focusing on company creation and early-stage financings

Joël Jean-Mairet, PhD

Joël Jean-Mairet, PhD

Ysios Capital


Managing partner and co-founder of Ysios Capital. Co-founded Glycart Biotechnology in 2001

Carl Kilander, MD PhD

Carl Kilander, MD PhD

HealthCap


Partner at HealthCap. Carl co-founded and was CEO of a health-tech start-up exited in 2019. Carl is a Medical Doctor trained at the Karolinska Institute and at Harvard Medical School

Sanne de Jongh, MSc

Sanne de Jongh, MSc

Gilde Healthcare


Investment Manager at Gilde Healthcare, where she focuses on the firms’ investment activities in the biopharmaceutical sector

 

Rez Halse, PhD

Rez Halse, PhD

RA Capital


President, RA Ventures at RA Capital Management. Rez’s primary responsibility is to lead early-stage private investments in companies developing drugs

Lars H. Engelholm, PhD

Lars H. Engelholm, PhD

Founder representative